Lilly colon cancer drug succeeds in late stage study
September 12, 2014 at 08:35 AM EDT
Sept 12 (Reuters) - Eli Lilly and Co said its colon cancer drug extended survival compared to a placebo, in a late stage trial.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.